Huppert M, Sun S H, Gleason-Jordon I, Vukovich K R
Infect Immun. 1976 Dec;14(6):1356-68. doi: 10.1128/iai.14.6.1356-1368.1976.
Evidence provided by histopathological study of lesions is a valuable adjunct for evaluating chemotherapeutic efficacy in experimental animal models, In addition, this should be correlated with a measure of disease severity in the same animal. The latter could be obtained by homogenization of infected organs and quantitative enumeration of viable cells of the etiological agent, but this would preclude histopathological studies in the same animal. Progression of disease in pulmonary infection is associated with replacement of air space by fluid, cells, and cellular debris. Therefore, an increase in lung weight should reflect severity of disease. Results with the murine model of coccidioidomycosis demonstrate that increasing lung weight parallels the increasing census of fungus cells in the lungs of both treated and nontreated infected mice. This was supported with evidence obtained from microscopic studies of lesions indicating that specific chemotherapy limited spread of the infection and inhibited multiplication of the fungus in the lung. Therefore, lung weight can be used as a measure of disease severity in the murine model of coccidioidomycosis.
病变的组织病理学研究提供的证据是评估实验动物模型中化疗疗效的宝贵辅助手段。此外,这应与同一动物疾病严重程度的测量结果相关联。后者可以通过感染器官的匀浆和病原体活细胞的定量计数来获得,但这将排除对同一动物进行组织病理学研究。肺部感染中疾病的进展与气腔被液体、细胞和细胞碎片替代有关。因此,肺重量的增加应反映疾病的严重程度。球孢子菌病小鼠模型的结果表明,肺重量的增加与治疗和未治疗的感染小鼠肺部真菌细胞数量的增加平行。从病变的显微镜研究获得的证据支持了这一点,表明特定化疗可限制感染的传播并抑制肺部真菌的繁殖。因此,在球孢子菌病小鼠模型中,肺重量可作为疾病严重程度的一种衡量指标。